91 related articles for article (PubMed ID: 6598)
1. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice.
Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW
J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598
[TBL] [Abstract][Full Text] [Related]
2. Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
Sidwell RW; Huffman JH; Schafer TW; Shipman C
Chemotherapy; 1990; 36(1):58-69. PubMed ID: 2155092
[TBL] [Abstract][Full Text] [Related]
3. Suppression of herpes simplex virus infection by phosphonoacetic acid.
Shipkowitz NL; Bower RR; Appell RN; Nordeen CW; Overby LR; Roderick WR; Schleicher JB; Von Esch AM
Appl Microbiol; 1973 Sep; 26(3):264-7. PubMed ID: 4356456
[TBL] [Abstract][Full Text] [Related]
4. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
5. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
Sloan BJ; Miller FA; McLean IW
Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
7. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
Fitzwilliam JF; Griffith JF
J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
Allen LB; Thompson JM; Huffman JH; Revankar GR; Tolman RL; Simon LN; Robins RK; Sidwell RW
Antimicrob Agents Chemother; 1975 Oct; 8(4):468-73. PubMed ID: 172008
[TBL] [Abstract][Full Text] [Related]
9. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of herpes encephalitis].
Mertens T
Immun Infekt; 1986 Jul; 14(4):143-7. PubMed ID: 2427437
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.
Shannon WM; Westbrook L; Arnett G; Daluge S; Lee H; Vince R
Antimicrob Agents Chemother; 1983 Oct; 24(4):538-43. PubMed ID: 6651280
[TBL] [Abstract][Full Text] [Related]
12. A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice.
Field HJ; Anderson JR; Efstathiou S
J Gen Virol; 1984 Apr; 65 ( Pt 4)():707-19. PubMed ID: 6323620
[TBL] [Abstract][Full Text] [Related]
13. Brovavir: its antiherpesviral activity and mode of action.
Machida H
Adv Exp Med Biol; 1990; 278():255-65. PubMed ID: 1963041
[No Abstract] [Full Text] [Related]
14. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate.
Kern ER; Richards JT; Overall JC; Glasgow LA
J Infect Dis; 1977 Apr; 135(4):557-67. PubMed ID: 192805
[TBL] [Abstract][Full Text] [Related]
15. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
De Clercq E; Luczak M
J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice.
Machida H; Ichikawa M; Kuninaka A; Saneyoshi M; Yoshino H
Antimicrob Agents Chemother; 1980 Feb; 17(2):109-14. PubMed ID: 7387135
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
Marks MI
J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of some beta-diketones. 3. Aryl bis(beta-diketones). Antiherpetic activity.
Diana GD; Carabateas PM; Salvador UJ; Williams GL; Zalay ES; Pancic F; Steinberg BA; Collins JC
J Med Chem; 1978 Jul; 21(7):689-92. PubMed ID: 209188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
